While the standard parameters defining CRS after specific T cell antibody therapy mostly include clinical characteristics of the patients, the criteria for HLH include laboratory markers such as cytopenia, elevated liver enzymes, ferritin, and CRP, as well as changes in coagulation factors [4,81]. Here, CRP is linked to hemophagocytic syndrome.